openPR Logo
Press release

Cystic Fibrosis Therapeutics Market || 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2030

09-02-2020 12:38 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Prophecy Market Insights

Prophecy Market Insights

Prophecy Market Insights

The global cystic fibrosis therapeutics market accounted for US$ 5.3 billion in 2019 and is estimated to be US$ 25.6 billion by 2029 and is anticipated to register a CAGR of 17.2%

The report "Global Cystic Fibrosis Therapeutics Market, By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, and CFTR Modulators), By Route of Administration (Oral drugs and Inhaled drugs), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

In Octber 2019, AbbVie, a research-based global biopharmaceutical company, and the Cystic Fibrosis Foundation announced a strategic collaboration in which AbbVie will develop a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator compound licensed from the Foundation. Under the terms of the agreement, AbbVie will advance the potentiator into clinical development for potential use in combination treatments for cystic fibrosis (CF).
In January 2020, AbbVie a research-based global biopharmaceutical company, and Allergan, a leading global pharmaceutical company, announced that Allergan has entered into definitive agreements to divest brazikumab (IL-23 inhibitor) and Zenpep (pancrelipase). These agreements are in conjunction with the ongoing regulatory approval process for AbbVie's acquisition of Allergan.
Analyst View:

Growing prevalence of Cystic Fibrosis (CF)

According to the data published by the Cystic Fibrosis Foundation, the occurrence of these hereditary disorders is growing constantly. In 2015, in the U.S., there were 28,983 patients as compared to 26,366 patients in 2010. Swelling year-on-year growth in the number of patient’s additional results in the growing demand for efficient and effective CF therapeutics. Some of the commercially available approved drug class are Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators, mucolytic drugs, bronchodilators drugs, anti-infective, anti-inflammatory drugs, antibiotics (oral, inhaled, or parental feeding formulae), and pancreatic enzyme supplements.

Growth in the number of initiatives concerning to development of NASH drugs

Favourable initiatives taken by regional and national nonprofit organizations is one of the key factors boosting the growth of the target market. These initiatives provide funding to CF patients. These organizations help in research & development activities of these therapeutics and improve the patient’s quality of life. For example, the North American Cystic Fibrosis Conference (NACFC) was formed in 1986 to offer a collaborative and educational forum to CF professionals to share improvements in R&D related to CF therapeutics.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Cystic Fibrosis Therapeutics Market”, By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, and CFTR Modulators), By Route of Administration (Oral drugs and Inhaled drugs), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029

Download Free sample copy of this report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4421

Key Market Insights from the report:

The global cystic fibrosis therapeutics market accounted for US$ 5.3 billion in 2019 and is estimated to be US$ 25.6 billion by 2029 and is anticipated to register a CAGR of 17.2%. The market report has been segmented on the basis of drug class, route of administration, and region.

By drug class, CFTR modulators estimated for the highest revenue due to the launch of new drug Orkambi. This drug is accountable for improving the function of defective protein caused by the CF gene. This drug class directly cures the primary cause of the disease. Additionally, CFTR modulators are projected to grow with a lucrative growth rate in the upcoming years.
By route of administration, oral route estimated for the highest share of closely 63.7% in 2019 due to the benefits associated with its administration such as ease and convenience of consumption without the help of a healthcare professional. Increasing awareness in developing economies about the benefits of oral drugs, which include pancreatic enzyme supplements and CFTR modulators is one of the crucial factors expected to fuel the demand for these drugs.
By region, North America estimated for the highest revenue share in 2019, owing to the growing number of patients suffering from cystic fibrosis. Additionally, initiatives taken by CF Foundation and Cystic Fibrosis Canada are one of the vital reasons that can be estimated for its maximum share. The Asia Pacific is projected to be the fastest-growing segment with a profitable growth rate. Moreover, growing awareness about CF disorders & treatment options is anticipated to fuel this segment throughout the forecast period.

Competitive Landscape:

The prominent player operating in the global cystic fibrosis therapeutics market includes AbbVie Inc., Hoffmann-La Roche Ltd., Allergan, Gilead Sciences, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Novartis AG, Alcresta Therapeutics Inc., AstraZeneca Plc., and Alaxia.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Request discount-
https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/4421

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered

Introduction
Study Deliverables
Study Assumptions
Scope of the Study
Research Methodology
Executive Summary
Opportunity Map Analysis
Market at Glance
Market Share (%) and BPS Analysis, by Region
Competitive Landscape
Heat Map Analysis
Market Presence and Specificity Analysis

Contact Us:
Mr Alex (Sales Manager)
Prophecy Market Insights
Phone: +1 860 531 2701
Email: sales@prophecymarketinsights.com“

About us:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystic Fibrosis Therapeutics Market || 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2030 here

News-ID: 2126412 • Views:

More Releases from Prophecy Market Insights

Compound Feeds and Additives Market to Reach USD 85.1 Billion by 2035
Compound Feeds and Additives Market to Reach USD 85.1 Billion by 2035
The Compound Feeds and Additives Market is experiencing remarkable growth as the demand for high-quality animal nutrition and sustainable livestock production continues to rise globally. According to recent projections, the market, valued at USD 24.8 billion in 2024, is expected to expand significantly to reach USD 85.1 billion by 2035, growing at a strong CAGR of 13.2% during the forecast period. This surge reflects the increasing focus on animal health, productivity,
Aerospace Cyber Security Market Projected to Reach USD 65.4 Billion by 2035
Aerospace Cyber Security Market Projected to Reach USD 65.4 Billion by 2035
The Aerospace Cyber Security Market is witnessing unprecedented growth as the aerospace industry increasingly embraces digitalization and connected technologies. According to recent industry insights, the global aerospace cyber security market was valued at USD 29.4 billion in 2024 and is projected to reach an impressive USD 65.4 billion by 2035, growing at a CAGR of 8.5% during the forecast period. This robust growth reflects the rising need for advanced cyber defense
Indoor Air Quality Market: Breathing Life into Healthy Living and Sustainable Workspaces
Indoor Air Quality Market: Breathing Life into Healthy Living and Sustainable Wo …
Author: Shweta R., Business Development Specialist, Prophecy Market Insights Introduction The quality of the air we breathe has become a critical public health concern and a business priority worldwide. As urbanization intensifies, populations grow, and workplaces become increasingly technology-driven, the demand for Indoor Air Quality (IAQ) solutions is on the rise. From homes and offices to hospitals, educational institutions, and industrial facilities, ensuring clean indoor air is no longer optional-it is a
[PDF] Surface Analysis Market: Unlocking Precision in Material Science and Industrial Innovation
[PDF] Surface Analysis Market: Unlocking Precision in Material Science and Indus …
Author: Shweta R., Business Development Specialist Introduction The Surface Analysis Market is transforming the way industries understand, optimize, and innovate across materials and products. From semiconductors and aerospace to healthcare and nanotechnology, surface analysis techniques provide unmatched insights into composition, structure, and properties at the micro and nano scale. In today's innovation-driven economy, surface analysis has become more than a laboratory technique-it's a strategic enabler for product performance, quality assurance, and sustainability. As

All 5 Releases


More Releases for Cystic

Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features. Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856 Top Company Profile Analysis in this Report- Cystic Fibrosis
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have
Cystic Fibrosis Therapeutics Market Research Reports 2017
This report studies sales (consumption) of Cystic Fibrosis Therapeutics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Vertex Pharmaceuticals , F. Hoffmann-La Roche , AbbVie , Gilead Science , Novartis , AstraZeneca , Bayer , Celtaxsys , Pharmaxis , ProQR Therapeutics , PTC Therapeutics
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports. Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis". Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs